GAD1 and encephalitis: For instance, in a case of anti-GAD (glutamic acid decarboxylase) encephalitis treated with DBS, the patient experienced a reduction in seizure frequency, with events decreasing from 90 to 160 per month in the six months before DBS implantation to 30–70 per month afterward [17].